...
首页> 外文期刊>ACS Omega >Altering the Regioselectivity of Cytochrome P450 BM3 Variant M13 toward Genistein through Protein Engineering and Variation of Reaction Conditions
【24h】

Altering the Regioselectivity of Cytochrome P450 BM3 Variant M13 toward Genistein through Protein Engineering and Variation of Reaction Conditions

机译:通过蛋白质工程改变细胞色素P450 BM3变体M13的细胞色素P450 BM3变体M13的区域选择性及反应条件的变异

获取原文

摘要

The biocatalysts responsible for the enzymatic synthesis of hydroxygenisteins, derivatives of genistein with multiple activities, usually show regioselective promiscuity, hydroxylating genistein to form a mixture of multiple products, which, in turn, results in a cumbersome separation and purification. Hence, it is highly desired to explore the underlying mechanism regulating the regioselectivity of hydroxylases. M13 is a variant of cytochrome P450 BM3 with oxidant activity toward genistein. Herein, genistein was demonstrated to be hydroxylated by M13 to form a mixture of 3′-hydroxygenistein (3′-OHG) and 8-hydroxygenistein (8-OHG), each giving 4% conversion with a ratio of 1:1. Protein engineering toward M13 was thus performed to improve its regioselectivity. When isoleucine at position 86 was mutated into cysteine, the resultant variant M13I86C displayed improved regioselectivity toward 3′-OHG with an increased conversion of 8.5%. The double mutation M13I86CP18W further boosted the conversion of 3′-OHG to 9.6%, and the ratio of 3′-OHG to 8-OHG increased to 12:1. Conversely, both CoCl_(2) and glucose 6-phosphate (G6P) could lead to more 8-OHG. When Co~(2+) reached 37.5 mM, M13I86CP18W could give an 8-OHG conversion of 22.4%. The maximal ratio of 8-OHG to 3′-OHG reached 130 when 62.5 mM Co~(2+) was included in the reaction mixture. With the increase of G6P from 10 to 40 mM, the conversion of M13I86CP18W to 8-OHG gradually increased to 22.6%, while the conversion to 3′-OHG decreased to 6%. Thus, both intrinsic residues and external reaction conditions can affect the regiospecificity of M13, which laid the foundation for the selection of suitable biocatalysts for the hydroxylation of genistein.
机译:负责羟基因素的酶促合成的生物催化剂,具有多种活性的核苷酸衍生物,通常呈现出羟基化的Genistein,形成多种产物的混合物,这反过来导致繁琐的分离和纯化。因此,强烈希望探讨调节羟基酶的区域选择性的潜在机制。 M13是细胞色素P450 BM3的变体,氧化剂活性偏向甘黄黄素。在此,将Genistein证明通过M13羟基化,形成3'-羟基根素(3'-OHG)和8-羟基根蛋白(8-OHG)的混合物,每个混合物均为4%的转化率为1:1。因此进行蛋白质工程以改善其区域选择性。当位于86位的异氨酸突变成半胱氨酸时,所得变体M13i86C朝向3'-OHG显示出改善的区域选择性,随着8.5%的转化率增加。双突变M13I86CP18W进一步提高了3'-OHG的转化率至9.6%,3'-OHG与8-OHG的比例增加至12:1。相反,COCl_(2)和葡萄糖6-磷酸(G6P)可能导致更高8-OHG。当CO〜(2+)达到37.5毫米时,M13i86CP18W可以给出8 ohg转换为22.4%。当在反应混合物中包含62.5mM CO〜(2+)时,8 OHg至3'-OHG的最大比率达到130。随着G6P的增加,从10〜40mm的增加,M13i86CP18W至8-OHG的转化逐渐增加至22.6%,而转化为3'-OHG降至6%。因此,本征残留物和外部反应条件都会影响M13的细胞状性,这为选择合适的生物催化剂用于Genistein的羟基化的基础。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号